美迈德生物
MDXG
4.43
-0.25
-5.34%
美迈德生物
US · MDXG
#3541 按市值排名
4.43
-0.25
-5.34%
实时 - 追踪5344个代码 - 心跳于17秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期(2026/Q3)披露持股的机构数量增加了3家。
- 机构持股总比例上升了0.4个百分点。
机构持股
- 机构持股比例
- 77.85% +0.43pp
- 机构数量
- 262 +3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund38.18%
VC/PE Fund19.34%
Hedge Fund15.19%
Public Company2.45%
Individual/Insider1.91%
Private Company1.26%
Family Office/Trust0.54%
Government Pension Fund0.32%
Bank/Investment Bank0.28%
Other20.54%
主要股东 截至 2026-06-30
Essex Woodlands Management, Inc.
19.34% · 28.20M 股
BlackRock
8.34% · 12.15M 股
Trigran Investments, Inc.
4.92% · 7.17M 股
Vanguard Capital Management, LLC
4.09% · 5.96M 股
State Street Global Advisors
3.83% · 5.58M 股
Nantahala Capital Management, LLC
3.27% · 4.77M 股
Paradigm Capital Management, Inc.
2.79% · 4.07M 股
Geode Capital Management, LLC
2.16% · 3.14M 股
AQR Capital Management
1.68% · 2.45M 股
Renaissance Technologies Corp.
1.68% · 2.44M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 31次买入 · 19次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Essex Woodlands Management, Inc. | -- | 19.34% |
| K. Newton | Independent Director | 0.28% |
| William Hulse | General Counsel & Chief Administrative Officer | 0.25% |
| Joseph Capper | Chief Executive Officer | 0.21% |
| Ricci Whitlow | Former Chief Operating Officer | 0.20% |
| Douglas Rice | Chief Financial Officer | 0.15% |
| James Bierman | Independent Director | 0.15% |
| William Hawkins | Independent Preferred Director | 0.14% |
| M. Behrens Wilsey | Independent Chairperson | 0.13% |
| Cato Laurencin | Independent Director | 0.11% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-01 | Douglas Rice | Chief Financial Officer | Sale to Issuer | -12,749 | $3.95 |
| 2026-06-23 | Kimberly Maersk-Moller | Former Officer | Sale to Issuer | -19,820 | $3.83 |
| 2026-06-09 | James Bierman | Independent Director | Other Acquisition | +50,913 | $3.64 |
| 2026-06-09 | William Hawkins | Independent Preferred Director | Other Acquisition | +50,913 | $3.64 |
| 2026-06-09 | Dorothy Puhy | Independent Director | Other Acquisition | +50,913 | $3.64 |
| 2026-06-09 | Tiffany Olson | Independent Director | Other Acquisition | +50,913 | $3.64 |
| 2026-06-09 | K. Newton | Independent Director | Other Acquisition | +50,913 | $3.64 |
| 2026-03-12 | William Hulse | General Counsel & Chief Administrative Officer | Sale to Issuer | -20,245 | $4.38 |
| 2026-03-12 | Kimberly Maersk-Moller | Former Officer | Sale to Issuer | -6,762 | $4.38 |
| 2026-03-09 | William Hulse | General Counsel & Chief Administrative Officer | Derivative Exercise and Sale | -61,460 | $4.50 |
| 2026-03-09 | William Hulse | General Counsel & Chief Administrative Officer | Derivative Exercise and Retained | +74,904 | $4.50 |
| 2026-03-09 | Douglas Rice | Chief Financial Officer | Derivative Exercise and Sale | -96,363 | $4.50 |
| 2026-03-09 | Douglas Rice | Chief Financial Officer | Derivative Exercise and Retained | +146,637 | $4.50 |
| 2026-03-09 | Kimberly Maersk-Moller | Former Officer | Derivative Exercise and Sale | -21,270 | $4.50 |
| 2026-03-09 | Kimberly Maersk-Moller | Former Officer | Derivative Exercise and Retained | +21,575 | $4.50 |
| 2026-03-03 | Joseph Capper | Chief Executive Officer | Other Acquisition | +371,094 | -- |
| 2026-03-03 | Joseph Capper | Chief Executive Officer | Other Derivative Acquisition | +310,574 | $5.10 |
| 2026-03-03 | William Hulse | General Counsel & Chief Administrative Officer | Other Acquisition | +74,987 | -- |
| 2026-03-03 | William Hulse | General Counsel & Chief Administrative Officer | Other Derivative Acquisition | +62,758 | $5.10 |
| 2026-03-03 | Douglas Rice | Chief Financial Officer | Other Acquisition | +74,163 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
美迈德生物 讨论区 0 条评论